Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lyme Disease | 2 | 2022 | 123 | 1.350 |
Why?
|
| Influenza, Human | 2 | 2025 | 203 | 1.130 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 116 | 0.940 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 135 | 0.910 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2025 | 39 | 0.860 |
Why?
|
| Coinfection | 1 | 2025 | 58 | 0.850 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 462 | 0.720 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2022 | 22 | 0.720 |
Why?
|
| Influenza B virus | 2 | 2025 | 10 | 0.700 |
Why?
|
| Borrelia burgdorferi | 1 | 2022 | 93 | 0.690 |
Why?
|
| Immunoturbidimetry | 1 | 2021 | 1 | 0.680 |
Why?
|
| Point-of-Care Systems | 3 | 2013 | 127 | 0.640 |
Why?
|
| Influenza A virus | 2 | 2025 | 119 | 0.640 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 148 | 0.630 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2018 | 9 | 0.580 |
Why?
|
| Latent Tuberculosis | 1 | 2018 | 23 | 0.560 |
Why?
|
| Specimen Handling | 1 | 2018 | 61 | 0.560 |
Why?
|
| Sensitivity and Specificity | 5 | 2023 | 1160 | 0.560 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 25 | 0.480 |
Why?
|
| Polymerase Chain Reaction | 2 | 2023 | 512 | 0.480 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 234 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 727 | 0.440 |
Why?
|
| Blood Glucose | 3 | 2022 | 494 | 0.420 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2022 | 450 | 0.350 |
Why?
|
| Lung | 1 | 2016 | 965 | 0.330 |
Why?
|
| Humans | 20 | 2025 | 64745 | 0.320 |
Why?
|
| Retrospective Studies | 4 | 2025 | 6800 | 0.310 |
Why?
|
| Clozapine | 1 | 2009 | 32 | 0.290 |
Why?
|
| Blood Cell Count | 1 | 2007 | 33 | 0.270 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 19 | 0.270 |
Why?
|
| Laboratories | 2 | 2018 | 27 | 0.240 |
Why?
|
| Hematocrit | 1 | 2005 | 33 | 0.230 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2013 | 221 | 0.220 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2023 | 45 | 0.200 |
Why?
|
| Male | 8 | 2025 | 30798 | 0.200 |
Why?
|
| Viral Load | 1 | 2024 | 228 | 0.200 |
Why?
|
| Prevalence | 2 | 2025 | 1432 | 0.190 |
Why?
|
| Serologic Tests | 1 | 2022 | 34 | 0.190 |
Why?
|
| Immunoassay | 1 | 2022 | 71 | 0.190 |
Why?
|
| Female | 8 | 2025 | 33740 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2023 | 543 | 0.190 |
Why?
|
| Ferritins | 1 | 2022 | 30 | 0.180 |
Why?
|
| Creatinine | 1 | 2022 | 135 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2022 | 211 | 0.180 |
Why?
|
| Antibodies, Bacterial | 1 | 2022 | 182 | 0.170 |
Why?
|
| Paraproteinemias | 1 | 2021 | 16 | 0.170 |
Why?
|
| False Positive Reactions | 1 | 2021 | 77 | 0.170 |
Why?
|
| Incidence | 1 | 2025 | 1409 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 1688 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2024 | 885 | 0.160 |
Why?
|
| Infant | 1 | 2025 | 1683 | 0.160 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 121 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2025 | 2050 | 0.150 |
Why?
|
| Middle Aged | 6 | 2025 | 18110 | 0.150 |
Why?
|
| Pathology, Clinical | 1 | 2018 | 21 | 0.140 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 324 | 0.140 |
Why?
|
| Aged | 4 | 2025 | 14839 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 506 | 0.140 |
Why?
|
| Adult | 5 | 2025 | 17235 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1592 | 0.130 |
Why?
|
| Liver | 1 | 2022 | 866 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 350 | 0.120 |
Why?
|
| Child | 1 | 2025 | 4602 | 0.110 |
Why?
|
| Young Adult | 1 | 2025 | 4776 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 6293 | 0.100 |
Why?
|
| Calibration | 1 | 2013 | 67 | 0.100 |
Why?
|
| Bias | 1 | 2013 | 116 | 0.090 |
Why?
|
| Massachusetts | 1 | 2018 | 2137 | 0.090 |
Why?
|
| Ultrafiltration | 1 | 2011 | 10 | 0.090 |
Why?
|
| Chemical Precipitation | 1 | 2011 | 12 | 0.090 |
Why?
|
| Amylases | 1 | 2011 | 12 | 0.090 |
Why?
|
| Creatine Kinase | 1 | 2011 | 42 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2018 | 810 | 0.080 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 171 | 0.080 |
Why?
|
| Loxapine | 1 | 2009 | 1 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2009 | 91 | 0.070 |
Why?
|
| Automation | 1 | 2007 | 55 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2009 | 275 | 0.060 |
Why?
|
| Albuminuria | 1 | 2006 | 29 | 0.060 |
Why?
|
| Albumins | 1 | 2006 | 40 | 0.060 |
Why?
|
| Oxygen | 1 | 2005 | 317 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 987 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 51 | 0.040 |
Why?
|
| Connecticut | 1 | 2020 | 88 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1274 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2020 | 201 | 0.040 |
Why?
|
| Cognition | 1 | 2023 | 501 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2020 | 296 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 3301 | 0.030 |
Why?
|
| Curriculum | 1 | 2018 | 603 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 553 | 0.010 |
Why?
|